Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
32.69(c) 32.58(c) 33.82(c) 38.42(c) 36.88(c) Last
496 396 523 953 1 167 999 1 840 702 1 018 611 Volume
+0.43% -0.34% +3.81% +13.60% -4.01% Change
More quotes
Financials (USD)
Sales 2020 4 273 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 674 M - -
P/E ratio 2020 -154x
Yield 2020 -
Sales 2021 4 478 M - -
Net income 2021 24,4 M - -
Net Debt 2021 527 M - -
P/E ratio 2021 194x
Yield 2021 -
Capitalization 4 703 M 4 703 M -
EV / Sales 2020 1,26x
EV / Sales 2021 1,17x
Nbr of Employees 5 300
Free-Float 72,5%
More Financials
Company
Covetrus, Inc is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. The Company operates in three segments: North America, Europe and APCA & Emerging Markets. The Company combines practice management software and supply chain distribution businesses with a technology-enabled prescription management platform and related pharmacy... 
More about the company
Notations Surperformance© of Covetrus, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about COVETRUS, INC.
01/13COVETRUS, INC. : Results of Operations and Financial Condition, Regulation FD Di..
AQ
01/06COVETRUS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
01/04COVETRUS : Presidio Announces Appointment of Christine Komola as New CFO
AQ
2020COVETRUS : Completes Separation from Former Parent Company
BU
2020COVETRUS, INC. : Submission of Matters to a Vote of Security Holders, Regulation..
AQ
2020Credit Suisse Adjusts Price Target for Covetrus to $20 From $17, Maintains Ne..
MT
2020COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Covetrus Narrows Q3 Loss Amid Higher Revenue, Ups Full Year Earnings Guidance
MT
2020COVETRUS : 3Q Earnings Snapshot
AQ
2020COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
2020Earnings Flash (CVET) COVETRUS Posts Q3 Revenue $1.13B, vs. Street Est of $1...
MT
2020COVETRUS : Announces Financial Results for Third Quarter of 2020
AQ
2020Covetrus Announces Financial Results for Third Quarter of 2020
GL
2020COVETRUS : Announces Third Quarter 2020 Earnings Release Date and Conference Cal..
AQ
2020Covetrus Announces Third Quarter 2020 Earnings Release Date and Conference Ca..
GL
More news
News in other languages on COVETRUS, INC.
01/11STRATÉGIE : les quatre meilleurs fonds US 2020
2020COVETRUS : schließt Abspaltung von früherer Muttergesellschaft ab
2020COVETRUS : se sépare entièrement de son ancienne société mère
2020COVETRUS : nomme Jamey Seely au poste d'avocate générale
2020COVETRUS : ernennt Jamey Seely zur Leiterin der Rechtsabteilung
More news
Analyst Recommendations on COVETRUS, INC.
More recommendations
Stock Trading Strategies
COVETRUS, INC. - 2020
The stock is approaching a major resistance level
BUY
More Stock Trading Analysis
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 30,00 $
Last Close Price 36,88 $
Spread / Highest target -5,10%
Spread / Average Target -18,7%
Spread / Lowest Target -34,9%
EPS Revisions
Managers and Directors
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Matthew J. Foulston Chief Financial Officer
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.28.32%4 703
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.24%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726